These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4039649)

  • 1. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF; Young GA; Khazan N
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.
    Young AM; Stephens KR; Hein DW; Woods JH
    J Pharmacol Exp Ther; 1984 Apr; 229(1):118-26. PubMed ID: 6142942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of self-administration.
    Balster RL; Lukas SE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):249-61. PubMed ID: 3888576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

  • 8. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
    Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
    Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of etorphine in Rhesus monkeys.
    Herling S; Woods JH
    Psychopharmacology (Berl); 1981; 72(3):265-7. PubMed ID: 6784144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure.
    Picker MJ; Negus SS; Craft RM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):563-8. PubMed ID: 2165617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppression of deprivation and antagonist-induced withdrawal in morphine-dependent rhesus monkeys.
    Gmerek DE
    Neuropeptides; 1984 Dec; 5(1-3):19-22. PubMed ID: 6099494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalbuphine, pentazocine, and butorphanol interactions with tripelennamine in mice.
    Schmidt WK; Marynowski ME; Smith C
    NIDA Res Monogr; 1986; 67():145-6. PubMed ID: 3092060
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective effects of narcotic antagonists.
    Haertzen CA
    Adv Biochem Psychopharmacol; 1973; 8(0):383-98. PubMed ID: 4795096
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice.
    Kuzmin AV; Gerrits MA; Zvartau EE; van Ree JM
    Eur Neuropsychopharmacol; 2000 Dec; 10(6):447-54. PubMed ID: 11115734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.